CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Nidhi Jani
/ Categories: Trending, Quarterly Results

Parag Milk Foods jumps 8 per cent on robust Q1FY19 numbers

Parag Milk Foods, a leading manufacturer and marketer of branded dairy products, reported its results for the quarter ended June 30, 2018 on Monday after market hours.

The company’s consolidated revenue for the quarter came in at Rs. 549.42 crore, registering 33.1 per cent yoy increase. This growth was driven by an increase in revenue from Milk Products by 41 per cent YoY which was led by growth in key product categories.

EBITDA for the quarter rose by 109.5 per cent yoy to Rs. 59.7 crore with a corresponding margin expansion of 397 bps. EBITDA margin for the quarter stood at 10.9 per cent. This margin expansion was aided by operating leverage and higher capacity utilizations.

The PAT for the quarter came in at Rs. 28.27 crore, yoy increase of 168.6 per cent. The PAT Margin stood at 5.1 per cent in Q1FY19.

On Tuesday, the stock opened at Rs. 332.60 per share, up by almost 4.5 per cent from its previous close of Rs. 318.20 and jumped by nearly 8 per cent on the BSE.

Previous Article Cipla Limited bags final approval for generic diclofenac sodium gel
Next Article Avanti Feeds dips on poor quarterly performance
Print
1229 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR